https://www.marketscreener.com/quote/stock/SAREPTA-THERAPEUTICS-INC-11204214/news/Sarepta-Therapeutics-and-Clinigen-Launch-a-Managed-Access-Program-to-Treat-Patients-with-Duchenne-Mu-24780976/?utm_source=telegram&utm_medium=social&utm_campaign=share